GEISTWERT Rechtsanwälte Lawyers Avvocati

https-www.unifiedpatentcourt.org-en-node-159789-c249a552bc86

Amgen Inc. v. Regeneron Pharmaceuticals Inc.

Date
2025-11-25
Division
Luxembourg (LU)
Type of action
Appeal RoP220.1
Language
EN

Metadata

Case IDhttps-www.unifiedpatentcourt.org-en-node-159789-c249a552bc86
Case number
Registry number
Order reference
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 35

1 DECISION of the Court of Appeal of the Unified Patent Court issued on 25 November 2025 concerning appeals in a revocation action and a counterclaim for revocation HEADNOTES Claim interpretation 1. The question of whether conclusions can be drawn from the subject matter of a dependent claim and its features when interpreting the main claim depends on the circumstances of the individual case. If the dependent claim is only adding an additional feature that does not provide a more specific description of the features of the main claim, it generally argues against the possibility of drawing conclusions about the interpretation of the main claim from this dependent claim. 2. When the claims are drafted in ‘medical use -format’, it is an inherent claim feature that the claimed product must be  ...